KO
44
-2
KMB
42
-3
SLB
48
2
EMR
70
2
STZ
52
3
WY
39
2
EMC
60
2
JBHT
52
-3
TRV
52
-3
R
76
5
SO
53
-4
CHD
35
3
PRU
76
14
WDC
66
3
AON
56
-4
LUV
75
13
BXP
39
-2
HBAN
74
-2
NKE
42
2
KSS
62
2
KO
44
-2
KMB
42
-3
SLB
48
2
EMR
70
2
STZ
52
3
WY
39
2
EMC
60
2
JBHT
52
-3
TRV
52
-3
R
76
5
SO
53
-4
CHD
35
3
PRU
76
14
WDC
66
3
AON
56
-4
LUV
75
13
BXP
39
-2
HBAN
74
-2
NKE
42
2
KSS
62
2
Financhill
Back

Innovent Biologics, Inc. 10K Form

Buy
56

IVBXF
Innovent Biologics, Inc.

Last Price:
$11.16
Seasonality Move:
5.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IVBXF News And Ratings

See the #1 stock for the next 7 days that we like better than IVBXF

IVBXF Financial Statistics

Sales & Book Value

Annual Sales: $1.3B
Cash Flow: $0
Price / Cash Flow: 142.55
Annual Sales: $1.10
Price / Book: 10.65

Profitability

EPS (TTM): 0.09540
Net Income (TTM): $156.5M
Gross Margin: $1.1B
Return on Equity: -0.75%
Return on Assets: -0.46%

Innovent Biologics, Inc. Earnings Forecast

Key Innovent Biologics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 9 years for IVBXF is 83.97%.
  • The Selling, General & Administrative Expenses for IVBXF have been equal to 53.97% of Gross Profit Margin.
  • The Research & Development expenses have been 28.46% of Revenue.
  • The Net Earning history of IVBXF is -1.00% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 5 years.

Innovent Biologics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: IVBXF
Website: innoventbio.com

Debt

Debt-to-Equity Ratio: 0.21
Current Ratio: 2.35
Quick Ratio: 2.16

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IVBXF Technical Analysis vs Fundamental Analysis

Buy
56
Innovent Biologics, Inc. (IVBXF) is a Buy

Is Innovent Biologics, Inc. a Buy or a Sell?